Skip to main content
. 2020 Jul 9;7(4):271–279. doi: 10.1007/s40801-020-00206-7
The effectiveness of gliclazide and gliclazide + metformin prescribed to Indian patients with type 2 diabetes mellitus during routine clinical practice in India was assessed using electronic medical record data.
Gliclazide or gliclazide + metformin was found to be effective in reducing HbA1C in Indian patients with type 2 diabetes mellitus.